Certificate under Regulation 74(5) of the SEBI (Depositories and Participants ) Regulation, 2018 for the quarter ended 30th june 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Brawn Biotech Ltd has submitted a compliance certificate under SEBI Regulation 74(5) for the quarter ending 30th June 2025. This certificate confirms that the company's Registrar and Share Transfer Agent has completed the reconciliation of share holdings with the depositories (NSDL and CDSL). The filing is part of routine quarterly compliance requirements applicable to all listed companies. No changes to share capital, business operations, or financial position are involved. It is a procedural submission confirming proper maintenance of dematerialised share records.
This is a routine regulatory filing with no material impact on the company's financials, operations, or share price. It simply confirms that share records are properly reconciled with depositories.